These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 28111827
1. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control? Daly A, Evans S, Chahal S, Santra S, MacDonald A. J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827 [Abstract] [Full Text] [Related]
4. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria. Daly A, Evans S, Pinto A, Jackson R, Ashmore C, Rocha JC, MacDonald A. Nutrients; 2020 Aug 14; 12(8):. PubMed ID: 32823853 [Abstract] [Full Text] [Related]
5. Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I. Daly A, Evans S, Pinto A, Ashmore C, MacDonald A. Nutrients; 2021 Sep 16; 13(9):. PubMed ID: 34579102 [Abstract] [Full Text] [Related]
6. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. Ahring KK, Dagnæs-Hansen F, Brüel A, Christensen M, Jensen E, Jensen TG, Johannsen M, Johansen KS, Lund AM, Madsen JG, Brøndum-Nielsen K, Pedersen M, Sørensen LK, Kjolby M, Møller LB. PLoS One; 2022 Sep 16; 17(1):e0261150. PubMed ID: 35015767 [Abstract] [Full Text] [Related]
8. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. Pinto A, Almeida MF, Ramos PC, Rocha S, Guimas A, Ribeiro R, Martins E, Bandeira A, MacDonald A, Rocha JC. Eur J Clin Nutr; 2017 Oct 16; 71(10):1230-1234. PubMed ID: 28402322 [Abstract] [Full Text] [Related]
11. A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes. Daly A, Högler W, Crabtree N, Shaw N, Evans S, Pinto A, Jackson R, Ashmore C, Rocha JC, Strauss BJ, Wilcox G, Fraser WD, Tang JCY, MacDonald A. Nutrients; 2021 Jun 17; 13(6):. PubMed ID: 34204378 [Abstract] [Full Text] [Related]
14. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria. Ney DM, Murali SG, Stroup BM, Nair N, Sawin EA, Rohr F, Levy HL. Mol Genet Metab; 2017 Jun 17; 121(2):96-103. PubMed ID: 28400091 [Abstract] [Full Text] [Related]
16. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis. Pena MJ, Pinto A, Daly A, MacDonald A, Azevedo L, Rocha JC, Borges N. Nutrients; 2018 Nov 18; 10(11):. PubMed ID: 30453665 [Abstract] [Full Text] [Related]
20. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria. Solverson P, Murali SG, Brinkman AS, Nelson DW, Clayton MK, Yen CL, Ney DM. Am J Physiol Endocrinol Metab; 2012 Apr 01; 302(7):E885-95. PubMed ID: 22297302 [Abstract] [Full Text] [Related] Page: [Next] [New Search]